PHC GROUPPHC Holdings Corporation

  • About Us
  • Group Companies
  • Products & Services
  • Sustainability
  • Investor Relations
  • Newsroom

About Us

About PHC GroupCEO MessageMission, Vision & ValuesValue Creation PlanHistory LeadershipPHC Group by the Numbers

Group Companies

Ascensia LSI Medience Wemex Mediford Epredia PHCbi PHC IVD

Products & Services

Cancer Pathology Biologic & Cell Preservation Diagnostic Testing Patient Record & Billing Software Diabetes Management Medical Device & Drug Delivery

Sustainability

Sustainability
  • CEO Message
  • Materiality
  • Sustainability Management
  • PHC GROUP Integrated Report
  • Stakeholder Engagement
  • Environment image
    Environment
  • Society image
    Social
  • Governance image
    Governance

Investor Relations

INVESTOR RELATIONS

MANAGEMENT

  • Corporate Governance
  • IR Basic Policy
  • Business Risks

IR LIBRARY

  • Financial Results
  • Presentation Materials
  • IR Materials
  • Historical Financial Data
  • PHC GROUP Integrated Report
  • Mid-term Plan
  • Our Group Introduction

STOCK INFORMATION

  • Stock Overview
  • General Meeting of Shareholders
  • Shareholder Newsletter
  • Stock Quotations
  • Analyst Coverage
IR News Financial Highlights IR Calendar Contact IR Disclaimer

Newsroom

NEWSROOM

NEWS

  • PHC Holdings Corporation
  • PHC Group Companies
CareersContact
JP

Other PHC Group Websites

  • Ascensia Diabetes Care Holdings AG
  • PHC Corporation
  • LSI Medience Corporation
  • Wemex Corporation
  • Mediford Corporation
  • Epredia Holdings Ltd.
  • PT PHC Indonesia
  • PHC Corporation of North America
  • PHC Europe B.V.
  • SciMed (ASIA) Pte Ltd
  • Amelieff Corporation

Other PHC Group Websites

  • Ascensia Diabetes Care Holdings AG
  • PHC Corporation
  • LSI Medience Corporation
  • Wemex Corporation
  • Mediford Corporation
  • Epredia Holdings Ltd.
  • PT PHC Indonesia
  • PHC Corporation of North America
  • PHC Europe B.V.
  • SciMed (ASIA) Pte Ltd
  • Amelieff Corporation
CareersContactJP
Newsroom > 2020 > Announcement of Directors at PHC Holdings Corporation, the PHC Group Executive Committee Members, and PHC Holdings Board of Directors Meeting Members Effective on April 1, 2020

News


2020

NewsMarch 30

Announcement of Directors at PHC Holdings Corporation, the PHC Group Executive Committee Members, and PHC Holdings Board of Directors Meeting Members Effective on April 1, 2020

Please be advised of the Board of Directors at PHC Holdings Corporation, the PHC Group Executive Committee members, and PHC Holdings Board of Directors Meeting Members effective on April 1, 2020.

(1) Resignation on March 31, 2020

Position/Title Name Remarks
Corporate Officer, for Special Missions,
Healthcare IT Alliance
Noboru Ohrui  

(2) Resignation on April 1, 2020

Position/Title Name Remarks
Corporate Officer,
Chief Transformation Officer (CTRO)
Peter Eckenberg  
Corporate Officer, Japan HR head,
Chief Administration Officer (CAO)
Ryuji Nakashima  
Corporate Officer, International HR head Myra Rosen  

(3) New Appointments of Corporate Officers in PHC Holdings Corporation on April 1, 2020

Position/Title Name Remarks
Corporate Officer,
Co-head of Life Sciences/Diagnostics Domain
Nobuaki Nakamura Director, Member of Board
Biomedical Division, PHC Corporation
Corporate Officer,
Co-head of Life Sciences/Diagnostics Domain
James Post President, Epredia
Corporate Officer,
Co-head of Healthcare Services Domain
Takayuki Otsuka Director, Member of Board
Medical information Systems Division,
PHC Corporation
Corporate Officer,
Co-head of Healthcare Services Domain
Haruo Watanabe President and Chief Executive Officer,
LSI Medience Corporation

(4) Board of Directors at PHC Holdings Corporation on April 1, 2020

Member of Board, Corporate Auditor

Position/Title Name Remarks
President,
Member of Board
Michael Kloss President,
Ascensia Diabetes Care Holdings AG
Executive Vice President,
Member of Board
Shoji Miyazaki President,
PHC Corporation
Director,
Member of Board
Hirofumi Hirano President,
KKR Japan Limited
Director,
Member of Board
Eiji Yatagawa Partner,
KKR Japan Limited
Director,
Member of Board
Hidekazu Tanaka General Manager, Healthcare Business Div.
Healthcare & Service Business Unit
MITSUI & CO., LTD.
Director,
Member of Board
Koichiro Sato General Manager, Healthcare Business 3rd Dept.
Healthcare Business Div.
Healthcare & Service Business Unit
MITSUI & CO., LTD.
Director,
Member of Board
Tatsunobu Fukushima General Manager,
Corporate Planning Department
Life Science Institute, Inc.
Corporate Auditor Koichi Ikeuchi Corporate Auditor,
PHC Corporation
Corporate Auditor
(Independent outside auditor)
Noriaki Yamada Clifix Certified Public Tax Accountant’s Corporation
Corporate Auditor Ken Matsumura Principal, KKR Japan Limited
Corporate Auditor Atsushi Shibata Manager, Healthcare Business 3rd Dept.
Healthcare Business Div.
Healthcare & Service Business Unit
MITSUI & CO., LTD.
Corporate Auditor Tatsuo Kuwajima Corporate Auditor,
Life Science Institute, Inc.

Corporate Officer

Position/Title Name Remarks
Chief Executive Officer (CEO) Michael Kloss President
President, Ascensia Diabetes Care Holdings AG
Chief Operating Officer (COO) Shoji Miyazaki Executive Vice President
President, PHC Corporation
Corporate Officer,
Chief Financial Officer (CFO)
Frederick Reidenbach  
Corporate Officer,
Chief Strategic Officer (CSO),
Corporate Planning, Business
Development and External Affairs
Ryuichi Hirashima  
Corporate Officer,
Head of Diabetes Management
Business Domain
Robert Schumm  
Corporate Officer, General Counsel Norio Ubukata  
Corporate Officer,
Chief Information Officer (CIO)
Takashi Mineshima  
Corporate Officer,
Engineering, and Manufacturing
Kyoji Morimoto  
Corporate Officer,
Co-head of Life Sciences/Diagnostics Domain
Nobuaki Nakamura Director, Member of Board
Biomedical Division, PHC Corporation
Corporate Officer,
Co-head of Life Sciences/Diagnostics Domain
James Post President, Epredia
Corporate Officer,
Co-head of Healthcare Services Domain
Takayuki Otsuka Director, Member of Board
Medical information Systems Division,
PHC Corporation
Corporate Officer,
Co-head of Healthcare Services Domain
Haruo Watanabe President and Chief Executive Officer,
LSI Medience Corporation

(5) The PHC Group Executive Committee Members on April 1, 2020

Position/Title Name Remarks
President,
Member of Board,
Chief Executive Officer (CEO)
Michael Kloss  
Executive Vice President,
Member of Board,
Chief Operating Officer (COO)
Shoji Miyazaki  
Corporate Auditor Koichi Ikeuchi  
Corporate Officer,
Chief Financial Officer (CFO)
Frederick Reidenbach  
Corporate Officer,
Chief Strategic Officer (CSO),
Corporate Planning, Business
Development and External Affairs
Ryuichi Hirashima  
Corporate Officer, General Counsel Norio Ubukata  

(6) Board of Directors Meeting Members at PHC Holdings Corporation on April 1, 2020

Position/Title Name Remarks
President,
Member of Board,
Chief Executive Officer (CEO)
Michael Kloss President,
Ascensia Diabetes Care Holdings AG
Executive Vice President,
Member of Board,
Chief Operating Officer (COO)
Shoji Miyazaki President,
PHC Corporation
Director,
Member of Board
Hirofumi Hirano President,
KKR Japan Limited
Director,
Member of Board
Eiji Yatagawa Partner,
KKR Japan Limited
Director,
Member of Board
Hidekazu Tanaka General Manager, Healthcare Business Div.
Healthcare & Service Business Unit
MITSUI & CO., LTD.
Director,
Member of Board
Koichiro Sato General Manager, Healthcare Business 3rd Dept.
Healthcare Business Div.
Healthcare & Service Business Unit
MITSUI & CO., LTD.
Director,
Member of Board
Tatsunobu Fukushima General Manager,
Corporate Planning Department
Life Science Institute, Inc.
Corporate Auditor Koichi Ikeuchi Corporate Auditor,
PHC Corporation
Corporate Auditor
(Independent outside auditor)
Noriaki Yamada Clifix Certified Public Tax Accountant’s Corporation
Corporate Auditor Ken Matsumura Principal, KKR Japan Limited
Corporate Auditor Atsushi Shibata Manager, Healthcare Business 3rd Dept.
Healthcare Business Div.
Healthcare & Service Business Unit
MITSUI & CO., LTD.
Corporate Auditor Tatsuo Kuwajima Corporate Auditor,
Life Science Institute, Inc.
Corporate Officer,
Chief Financial Officer (CFO)
Frederick Reidenbach  
Corporate Officer,
Chief Strategic Officer (CSO),
Corporate Planning, Business
Development and External Affairs
Ryuichi Hirashima  
Corporate Officer, General Counsel Norio Ubukata  

Media contact

Corporate Communications Group
PHC Holdings Corporation
+81-3-6778-5311

  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
Terms of UsePrivacy PolicyFacebookLinkedIn © PHC Holdings Corporation All rights reserved.